On Monday, Cg Oncology Inc (NASDAQ: CGON) opened lower -3.07% from the last session, before settling in for the closing price of $26.72. Price fluctuations for CGON have ranged from $14.80 to $40.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -29.42% at the time writing. With a float of $44.88 million, this company’s outstanding shares have now reached $76.22 million.
Let’s determine the extent of company efficiency that accounts for 113 employees. In terms of profitability, gross margin is 98.94%, operating margin of -20302.27%, and the pretax margin is -15945.17%.
Cg Oncology Inc (CGON) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cg Oncology Inc is 41.12%, while institutional ownership is 67.92%. The most recent insider transaction that took place on May 21 ’25, was worth 28,000. In this transaction Director of this company sold 1,000 shares at a rate of $28.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Apr 28 ’25, when Company’s Director sold 1,000 for $30.76, making the entire transaction worth $30,760. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.42% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Check out the current performance indicators for Cg Oncology Inc (CGON). In the past quarter, the stock posted a quick ratio of 30.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2991.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.81 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Looking closely at Cg Oncology Inc (NASDAQ: CGON), its last 5-days average volume was 0.91 million, which is a drop from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 51.01%.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 63.43%, which indicates a significant increase from 28.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.03 in the past 14 days, which was lower than the 1.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.94, while its 200-day Moving Average is $28.98. However, in the short run, Cg Oncology Inc’s stock first resistance to watch stands at $26.50. Second resistance stands at $27.11. The third major resistance level sits at $27.57. If the price goes on to break the first support level at $25.44, it is likely to go to the next support level at $24.98. Now, if the price goes above the second support level, the third support stands at $24.37.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
There are currently 76,225K shares outstanding in the company with a market cap of 1.97 billion. Presently, the company’s annual sales total 1,140 K according to its annual income of -88,040 K. Last quarter, the company’s sales amounted to 50 K and its income totaled -34,450 K.
